Project Number 1R41AG081004-01 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for AAV-AIBP Therapy for Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator JU, WONKYU Principal Investigator First Name WONKYU Principal Investigator Last Name JU Awardee Organization RAFT PHARMACEUTICALS, LLC Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-317: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) FY Overall Cost $247,056 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
